末端补体复合体C5b-9(C5b-9)等多因子检测试剂盒(流式荧光发光法)
Multiplex Assay Kit for Terminal Complement Complex C5b-9 (C5b-9) ,etc. by FLIA (Flow Luminescence Immunoassay)
MAC; Membrane Attack Complex
(注:单次混测多因子不超过8个指标 )
- 编号LMC350Po
- 物种Sus scrofa; Porcine (Pig,猪) 相同的名称,不同的物种。
- 实验方法双抗夹心
- 反应时长3.5h
- 检测范围0.05-50ng/mL
- 灵敏度最小可检测剂量小于等于0.017 ng/mL.
- 样本类型Plasma, tissue homogenates and other biological fluids
- 下载 英文说明书 中文说明书
- 规格 8指标数 7指标数 6指标数 5指标数 4指标数 3指标数 2指标数1指标数
- 价格 ¥ 3145 ¥ 3266 ¥ 3447 ¥ 3689 ¥ 3931 ¥ 4294 ¥ 4838 计算器 ¥ 6048 添加到价格计算器
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
特异性
本试剂盒用于检测末端补体复合体C5b-9(C5b-9)等多因子检测试剂盒(流式荧光发光法),经检测与其它相似物质无明显交叉反应。
由于受到技术及样本来源的限制,不可能完成对所有相关或相似物质交叉反应检测,因此本试剂盒有可能与未经检测的其它物质有交叉反应。
回收率
分别于定值血清及血浆样本中加入一定量的末端补体复合体C5b-9(C5b-9)等多因子检测试剂盒(流式荧光发光法)(加标样品),重复测定并计算其均值,回收率为测定值与理论值的比率。
样本 | 回收率范围(%) | 平均回收率(%) |
serum(n=5) | 98-105 | 101 |
EDTA plasma(n=5) | 99-105 | 102 |
heparin plasma(n=5) | 97-104 | 101 |
sodium citrate plasma(n=5) | 87-95 | 91 |
精密度
精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100
批内差:取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次,分别计算不同浓度样本的平均值及SD值。
批间差:选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定,每个样本使用同一试剂盒重复测定8次,分别计算不同浓度样本的平均值及SD值。
批内差: CV<10%
批间差: CV<12%
线性
在定值血清及血浆样本内加入适量的末端补体复合体C5b-9(C5b-9)等多因子检测试剂盒(流式荧光发光法),并倍比稀释成1:2,1:4,1:8,1:16的待测样本,线性范围即为稀释后样本中末端补体复合体C5b-9(C5b-9)等多因子检测试剂盒(流式荧光发光法)含量的测定值与理论值的比率。
样本 | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 83-93% | 96-104% | 82-104% | 83-94% |
EDTA plasma(n=5) | 90-99% | 90-104% | 91-101% | 94-105% |
heparin plasma(n=5) | 83-97% | 94-101% | 93-101% | 97-105% |
sodium citrate plasma(n=5) | 80-103% | 78-96% | 83-102% | 84-97% |
稳定性
经测定,试剂盒在有效期内按推荐温度保存,其活性降低率小于5%。
为减小外部因素对试剂盒破坏前后检测值的影响,实验室的环境条件需尽量保持一致,尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。
实验流程
1. 实验前标准品、试剂及样本准备;
2. 加样(标准品、样本、磁珠)标准品或样本100μL及磁珠10μL,
37°C酶标板振荡器孵育90分钟;
3. 磁吸甩干,加检测溶液A100μL,37°C酶标板振荡器孵育60分钟;
4. 磁吸洗板3次;
5. 加检测溶液B100μL,37°C振动孵育30分钟;
6. 磁吸洗板3次;
7. 加鞘液100μL,旋涡震荡2分钟后读数。
实验原理
将末端补体复合体C5b-9(C5b-9)等多因子检测试剂盒(流式荧光发光法)抗体包被于磁珠,制成固相载体,向微孔中分别加入标准品或标本以及磁珠,其中的末端补体复合体C5b-9(C5b-9)等多因子检测试剂盒(流式荧光发光法)与连接于固相载体上的抗体结合,然后加入生物素化的末端补体复合体C5b-9(C5b-9)等多因子检测试剂盒(流式荧光发光法)抗体,将未结合的生物素化抗体洗净后,加入PE标记的亲和素,再次彻底洗涤后即可上机读数。MFI值和样品中的末端补体复合体C5b-9(C5b-9)等多因子检测试剂盒(流式荧光发光法)呈正相关。
赠品
增值服务
相关产品
编号 | 适用物种:Sus scrofa; Porcine (Pig,猪) | 应用(仅供研究使用,不用于临床诊断!) |
LMC350Po | 末端补体复合体C5b-9(C5b-9)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
杂志 | 参考文献 |
Journal of Biomedical Materials Research Part A | Effect of thiol functionalization on the hemo-compatibility of PLGA nanoparticles [Wiley: source] |
The Journal of Clinical Investigation | Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis [PubMed: PMC3195471] |
Colloids and Surfaces B: Biointerfaces | Glucosylated polymeric nanoparticles: A sweetened approach against blood compatibility paradox [ScienceDirect: S0927776513001720] |
Perfusion | The effect of normovolemic modified ultrafiltration on inflammatory mediators, endotoxins, terminal complement complexes and clinical outcome in high-risk cardiac surgery patients [Pubmed: 23429100] |
Nephrology Dialysis Transplantation | The efficacy of recombinant human soluble thrombomodulin for the treatment of shiga toxin associated hemolytic uremic syndrome model mice [Pubmed:25694534] |
journal of neuroinflammation | Adjuvant treatment with dexamethasone plus anti-C5 antibodies improves outcome of experimental pneumococcal meningitis: a randomized controlled trial [PubMed: 26272468] |
J Thromb Haemost | Thrombin‐activatable fibrinolysis inhibitor influences disease severity in humans and mice with pneumococcal meningitis [PubMed: 26340319] |
Digital Repository | Dosagem de frações ativadas do sistema complemento em empiema induzido em ratos [10183] |
J Neuroinflammation. | Mannose-binding lectin-associated serine protease 2 (MASP-2) contributes to poor disease outcome in humans and mice with pneumococcal meningitis [PMC5234106] |
Cancer Letters | Complement C5a/C5aR pathway potentiates the pathogenesis Q5 of gastric cancer by down-regulating p21 expression [pubmed:29031586] |
Effects of immunoadsorption combined with membrane filtration on complement markers–Results of a randomized, controlled, crossover study [] | |
Journal of Neuroinflammation | Complement factor H contributes to mortality in humans and mice with bacterial meningitis [Pubmed: 31883521] |
FASEB J | C‐reactive protein inhibits C3a/C3aR‐dependent podocyte autophagy in favor of diabetic kidney disease [Pubmed:35503088] |